As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
For now, Eli Lilly’s orforglipron appears to be the top contender in the weight loss pill space due to its strong efficacy data and ease of use.
They will pay a combined $9.3 million after the Securities and Exchange Commission charged them for exceeding clients' investment limits...
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the...
Workers United represents more than 490 of Starbucks' U.S. cafes and more than 10,000 of its employees.
The changes come a day before Southwest's investor day, when executives will map out the company's plan to cut costs...
Birria has become a popular protein option for tacos, quesadillas, grilled cheese and even ramen.
Visa and MasterCard have surged in the past two decades, reaching a combined $1 trillion market cap. That has attracted...